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Cell counting measurements are critical in the research, development, and manufacturing of cell therapy products 
where they support decision-making in product testing and release.  Evaluating cell quantity with accuracy and 
precision has remained a challenge for many specific applications or purposes. While new measurement 
platforms have been developed with increased measurement throughput and improved precision, discrepancies 
between cell counts acquired via various measurement processes are still pervasive. In addition, the industry as a 
whole has recognized that complex biological properties, as well as operator, equipment, and procedure 
variations can greatly affect the measurement quality, and the development of a single reference material or 
reference measurement is impractical to address broad counting needs. 
 
Here, we describe an experimental design and statistical analysis approach to evaluate the quality of a given cell 
counting measurement process. The experimental design uses a dilution series study with replicate samples as 
well as procedures to reduce pipetting error, and operator and temporal bias. The statistical analysis methods 
generate a set of metrics for evaluating measurement quality in terms of accuracy and precision, where accuracy 
is based on deviation from proportionality. In this design, a proportional response to dilution fraction serves as an 
internal control, where deviation from a proportional response is indicative of a systematic or non-systematic bias 
in the measurement process. The utility of this approach was demonstrated in the counting of human 
mesenchymal stem cells (hMSC) via automated or manual counting methods, where the automated method 
performed better in terms of both precision and proportionality. These results enabled a transition from the labor 
intensive and often imprecise manual counting method to the automated counting method.   
 
The experimental design and statistical method presented here is agnostic to the cell type and analytical platform, 
thus suitable as a horizontal approach to evaluate the quality of cell counting measurements with respect to 
method selection, optimization, and validation, thereby facilitating subsequent decision making. We are also 
working closely with industry partners and Standards Development Organizations (SDOs) to develop cell counting 
standards using this and other strategies.   
